CoChat

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis

Open access
Kim, Eun Ho, Song, Hyo Sook, Yoo, Seung Hoon, Yoon, Myonggeun · 2016 · Oncotarget
Cited by 144

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Eun Ho Kim 1 , Hyo Sook Song 2 , Seung Hoon Yoo 1 , Myonggeun Yoon 2 1 Korea Institute of Radiological and Medical Sciences, Seoul, Korea 2 Department of Bio-Convergence Engineering, Korea University, Seoul, Korea Correspondence to: Myonggeun Yoon, email: radioyoon@korea.ac.kr Keywords: tumor treating fields, glioblastoma multiforme, NF-kB, metastasis, angiogenesis Received: March 15, 2016 Accepted: August 10, 2016 Published: August 18, 2016 ABSTRACT Treatment with alternating electric fields at an intermediate frequency (100–300 kHz), referred to as tumor treating fields (TTF) therapy, inhibits cancer cell proliferation. In the present study, we demonstrated that TTF application suppressed the metastatic potential of U87 and U373 glioblastoma cell lines via the NF-kB, MAPK and PI3K/AKT signaling pathways. Wound-healing and transwell assays showed that TTF suppressed cell migration and invasion compared with controls. Soft agar and three-dimensional culture assays showed that TTF inhibited both anchorage-dependent (cell proliferation) and anchorage-independent (colony formation) GBM cell growth. TTF dysregulated epithelial-to-mesenchymal transition-related genes, such as vimentin and E-cadherin, which partially accounted for TTF inhibition of cell migration and invasion. We further demonstrated that TTF application suppressed angiogenesis by downregulating VEGF, HIF1α and matrix metalloproteinases 2 and 9. TTF also inhibited NF-kB transcriptional activity. Collectively, our findings show that TTF represents a promising novel anti-invasion and anti-angiogenesis therapeutic strategy for use in GBM patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.11372

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 144

Metadata

Authors
Kim, E. H., Song, H. S., Yoo, S. H., & Yoon, M.
Venue
Oncotarget
Published
2016-08-18
Volume
7
Issue
40
Pages
65125-65136
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2513363024
Cited by
144
References
12
FWCI
6.93
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.